Respimat
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Respimat, covering 2021-06-04 to 2023-12-14. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique. [Phase 4]